XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions
Sep. 29, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 3.5 $ 2.3
Restricted cash 0.6 0.3
Accounts and other receivables, net of allowances of $0.5 and $0.7, respectively 75.2 59.9
Inventories 93.5 95.9
Current assets held-for-sale 22.1 8.9
Other current assets 1.5 1.5
Total current assets 196.4 168.8
Non-current assets    
Property, plant and equipment, net 65.7 63.8
Right-of-use assets from operating leases 13.7 15.4
Goodwill 69.5 67.5
Intangibles, net 11.9 12.0
Deferred tax assets 3.1 3.9
Investments and loans to joint ventures and other affiliates 0.4 0.4
Pensions and other retirement benefits 44.1 40.3
Total assets 404.8 372.1
Current liabilities    
Current maturities of long-term debt and short-term borrowing 3.7 4.6
Accounts payable 27.7 26.5
Accrued liabilities 33.3 20.9
Taxes on income 8.5 0.0
Current liabilities held-for-sale 7.2 3.9
Other current liabilities 9.9 8.9
Total current liabilities 90.3 64.8
Non-current liabilities    
Long-term debt 65.8 67.6
Pensions and other retirement benefits 0.0 0.1
Deferred tax liabilities 10.2 10.2
Other non-current liabilities 13.4 16.8
Total liabilities 179.7 159.5
Commitments and contingencies (Note 16)
Shareholders' equity    
Ordinary shares of £0.50 par value; authorized 40,000,000 shares for 2024 and 2023; issued 28,944,000 for 2024 and 2023; outstanding 26,784,848 and 26,834,628 for 2024 and 2023, respectively 26.5 26.5
Additional paid-in capital 224.8 223.5
Treasury shares (24.2) (22.9)
Company shares held by ESOP (0.8) (0.9)
Retained earnings 108.7 104.3
Accumulated other comprehensive loss (109.9) (117.9)
Total shareholders' equity 225.1 212.6
Total liabilities and shareholders' equity $ 404.8 $ 372.1
Common stock, shares outstanding (in shares) 26,784,848 26,834,628